{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T16:24:33Z","timestamp":1778343873840,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Open Project of Jiangsu Provincial Science and Technology Resources (Clinical Resources) Coordination Service Platform","award":["TC2023B004"],"award-info":[{"award-number":["TC2023B004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04002-9","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T22:06:56Z","timestamp":1739484416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of a prediction model for in-hospital mortality in immunocompromised chronic kidney diseases patients with severe infection"],"prefix":"10.1186","volume":"26","author":[{"given":"Yang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunni","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixuan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shutian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"4002_CR1","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00134-017-4857-2","volume":"43","author":"M Darmon","year":"2017","unstructured":"Darmon M, Ranzani OT, Azoulay E. Focus on immunocompromised patients. Intensive Care Med. 2017;43:1415\u20137.","journal-title":"Intensive Care Med"},{"issue":"Suppl 2","key":"4002_CR2","doi-asserted-by":"publisher","first-page":"S156","DOI":"10.1093\/infdis\/jiaa320","volume":"222","author":"RJ McCreery","year":"2020","unstructured":"McCreery RJ, Florescu DF, Kalil AC. Sepsis in Immunocompromised patients without Human Immunodeficiency Virus. J Infect Dis. 2020;222(Suppl 2):S156\u201365.","journal-title":"J Infect Dis"},{"key":"4002_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801.","journal-title":"JAMA"},{"key":"4002_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s15010-019-01277-7","volume":"47","author":"SE Battle","year":"2019","unstructured":"Battle SE, Augustine MR, Watson CM, Bookstaver PB, Kohn J, Owens WB, et al. Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection. Infection. 2019;47:571\u20138.","journal-title":"Infection"},{"key":"4002_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/qjmed\/hct046","volume":"106","author":"J Merayo-Chalico","year":"2013","unstructured":"Merayo-Chalico J, Gomez-Martin D, Pineirua-Menendez A, Santana-De Anda K, Alcocer-Varela J. Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study. QJM. 2013;106:451\u20137.","journal-title":"QJM"},{"key":"4002_CR6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2215\/CJN.07300712","volume":"8","author":"R Goupil","year":"2013","unstructured":"Goupil R, Brachemi S, Nadeau-Fredette A-C, D\u00e9ziel C, Troyanov Y, Lavergne V, et al. Lymphopenia and Treatment-related infectious complications in ANCA-Associated Vasculitis. Clin J Am Soc Nephrol. 2013;8:416\u201323.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4002_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/rheumatology\/kez349","volume":"59","author":"S Subesinghe","year":"2020","unstructured":"Subesinghe S, Kleymann A, Rutherford AI, Bechman K, Norton S, Benjamin Galloway J. The association between Lymphopenia and serious infection risk in rheumatoid arthritis. Rheumatology. 2020;59:762\u20136.","journal-title":"Rheumatology"},{"key":"4002_CR8","doi-asserted-by":"publisher","first-page":"796656","DOI":"10.3389\/fcimb.2022.796656","volume":"12","author":"H Lin","year":"2022","unstructured":"Lin H, Yang L, Fang J, Gao Y, Zhu H, Zhang S, et al. Clinical characteristics of bloodstream infection in immunosuppressed patients: a 5-Year retrospective cohort study. Front Cell Infect Microbiol. 2022;12:796656.","journal-title":"Front Cell Infect Microbiol"},{"key":"4002_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06197-w","author":"F Assan","year":"2022","unstructured":"Assan F, Bay P, Mathian A, Hekimian G, Brechot N, Quentric P, et al. In-ICU-acquired infections in flare-up systemic rheumatic disease patients receiving immunosuppressant. Clin Rheumatol. 2022;41:2845\u201354. https:\/\/doi.org\/10.1007\/s10067-022-06197-w","journal-title":"Clin Rheumatol"},{"key":"4002_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jcrc.2021.03.014","volume":"64","author":"A Van de Louw","year":"2021","unstructured":"Van de Louw A, Rello J, Martin-Loeches I, Mokart D, Metaxa V, Benoit D, et al. Bacteremia in critically ill immunocompromised patients with acute hypoxic respiratory failure: a post-hoc analysis of a prospective multicenter multinational cohort. J Crit Care. 2021;64:114\u20139.","journal-title":"J Crit Care"},{"key":"4002_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","volume":"23","author":"S Lambden","year":"2019","unstructured":"Lambden S, Laterre PF, Levy MM, Francois B. The SOFA score\u2014development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019;23:374.","journal-title":"Crit Care"},{"key":"4002_CR12","doi-asserted-by":"publisher","first-page":"18751","DOI":"10.1038\/s41598-024-69332-4","volume":"14","author":"L Zhang","year":"2024","unstructured":"Zhang L, Li X, Huang J, Yang Y, Peng H, Yang L, et al. Predictive model of risk factors for 28-day mortality in patients with sepsis or sepsis-associated delirium based on the MIMIC-IV database. Sci Rep. 2024;14:18751.","journal-title":"Sci Rep"},{"key":"4002_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/SHK.0000000000000234","volume":"42","author":"AM Drewry","year":"2014","unstructured":"Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS. Persistent Lymphopenia after diagnosis of Sepsis predicts Mortality. Shock. 2014;42:383\u201391.","journal-title":"Shock"},{"key":"4002_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00068-015-0585-x","volume":"42","author":"PE Vulliamy","year":"2016","unstructured":"Vulliamy PE, Perkins ZB, Brohi K, Manson J. Persistent lymphopenia is an independent predictor of mortality in critically ill emergency general surgical patients. Eur J Trauma Emerg Surg. 2016;42:755\u201360.","journal-title":"Eur J Trauma Emerg Surg"},{"key":"4002_CR15","doi-asserted-by":"publisher","first-page":"e15021","DOI":"10.1111\/ctr.15021","volume":"37","author":"ZA Yetmar","year":"2023","unstructured":"Yetmar ZA, Duffy D, Smith BH, Vikram HR, Brumble L, Limper AH, et al. Risk factors and outcomes of Pneumocystis pneumonia in solid organ transplant recipients: impact of posttransplant lymphoproliferative disorder. Clin Transpl. 2023;37:e15021.","journal-title":"Clin Transpl"},{"key":"4002_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13613-017-0242-0","volume":"7","author":"C Adrie","year":"2017","unstructured":"Adrie C, Lugosi M, Sonneville R, Souweine B, Ruckly S, Cartier J-C, et al. Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission. Ann Intensive Care. 2017;7:30.","journal-title":"Ann Intensive Care"},{"key":"4002_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1177\/08850666241226877","volume":"39","author":"J Jing","year":"2024","unstructured":"Jing J, Wei Y, Dong X, Li D, Zhang C, Fang Z, et al. Characteristics and clinical prognosis of septic patients with persistent Lymphopenia. J Intensive Care Med. 2024;39:733\u201341.","journal-title":"J Intensive Care Med"},{"key":"4002_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/SHK.0000000000002284","volume":"61","author":"D Adigbli","year":"2024","unstructured":"Adigbli D, Liu R, Meyer J, Cohen J, Di Tanna GL, Gianacas C, et al. Early persistent Lymphopenia and Risk of Death in critically ill patients with and without Sepsis. Shock. 2024;61:197\u2013203.","journal-title":"Shock"},{"key":"4002_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13613-023-01109-w","volume":"13","author":"T Daix","year":"2023","unstructured":"Daix T, Mathonnet A, Brakenridge S, Dequin P-F, Mira J-P, Berbille F, et al. Intravenously administered interleukin-7 to reverse Lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial. Ann Intensive Care. 2023;13:17.","journal-title":"Ann Intensive Care"},{"key":"4002_CR20","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature14468","volume":"523","author":"EF McKinney","year":"2015","unstructured":"McKinney EF, Lee JC, Jayne DRW, Lyons PA, Smith KGC. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature. 2015;523:612\u20136.","journal-title":"Nature"},{"key":"4002_CR21","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/art.40014","volume":"69","author":"D Comte","year":"2017","unstructured":"Comte D, Karampetsou MP, Kis-Toth K, Yoshida N, Bradley SJ, Kyttaris VC, et al. Brief report: CD4\u2009+\u2009T cells from patients with systemic Lupus Erythematosus respond poorly to exogenous Interleukin-2. Arthritis Rheumatol. 2017;69:808\u201313.","journal-title":"Arthritis Rheumatol"},{"key":"4002_CR22","doi-asserted-by":"crossref","unstructured":"Yap DYH, Chan TM. B cell abnormalities in systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of immunosuppressive treatments. Int J Mol Sci. 2019;20.","DOI":"10.3390\/ijms20246231"},{"key":"4002_CR23","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1093\/rheumatology\/keaa094","volume":"59","author":"T Katsuyama","year":"2020","unstructured":"Katsuyama T, Martin-Delgado IJ, Krishfield SM, Kyttaris VC, Moulton VR. Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus. Rheumatology (Oxford). 2020;59:2146\u201355.","journal-title":"Rheumatology (Oxford)"},{"key":"4002_CR24","doi-asserted-by":"publisher","first-page":"115503","DOI":"10.1016\/j.bcp.2023.115503","volume":"211","author":"H Chen","year":"2023","unstructured":"Chen H, Tan C, Wang Z, Zha J, Liu H, Dong Z, et al. Long-term glucocorticoid exposure persistently impairs CD4\u2009+\u2009T cell biology by epigenetically modulating the mTORC1 pathway. Biochem Pharmacol. 2023;211:115503.","journal-title":"Biochem Pharmacol"},{"key":"4002_CR25","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41590-022-01224-z","volume":"23","author":"JA Belk","year":"2022","unstructured":"Belk JA, Daniel B, Satpathy AT. Epigenetic regulation of T cell exhaustion. Nat Immunol. 2022;23:848\u201360.","journal-title":"Nat Immunol"},{"key":"4002_CR26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank CU, Haining WN, Held W, Hogan PG, Kallies A, Lugli E, et al. Defining T cell exhaustion. Nat Rev Immunol. 2019;19:665\u201374.","journal-title":"Nat Rev Immunol"},{"key":"4002_CR27","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ymthe.2021.12.013","volume":"30","author":"S Huang","year":"2022","unstructured":"Huang S, Liu D, Sun J, Zhang H, Zhang J, Wang Q, et al. Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-\u03baB signaling pathway in CD4 T cells. Mol Ther. 2022;30:1227\u201338.","journal-title":"Mol Ther"},{"key":"4002_CR28","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1097\/CCM.0000000000005047","volume":"49","author":"D Guinault","year":"2021","unstructured":"Guinault D, Nicolau-Travers ML, Silva S, Cointault O, Daniau B, Del Bello A, et al. Expression of exhaustion markers on CD8\u2009+\u2009T-Cell patterns predict outcomes in septic patients admitted to the ICU. Crit Care Med. 2021;49:1513\u201323.","journal-title":"Crit Care Med"},{"key":"4002_CR29","doi-asserted-by":"publisher","first-page":"2212080","DOI":"10.1080\/0886022X.2023.2212080","volume":"45","author":"M Liang","year":"2023","unstructured":"Liang M, Ren X, Huang D, Ruan Z, Chen X, Qiu Z. The association between lactate dehydrogenase to serum albumin ratio and the 28-day mortality in patients with sepsis-associated acute kidney injury in intensive care: a retrospective cohort study. Ren Fail. 2023;45:2212080.","journal-title":"Ren Fail"},{"key":"4002_CR30","doi-asserted-by":"publisher","first-page":"652383","DOI":"10.3389\/fimmu.2021.652383","volume":"12","author":"G Tang","year":"2021","unstructured":"Tang G, Tong S, Yuan X, Lin Q, Luo Y, Song H, et al. Using routine laboratory markers and immunological indicators for Predicting Pneumocystis Jiroveci Pneumonia in Immunocompromised patients. Front Immunol. 2021;12:652383.","journal-title":"Front Immunol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04002-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04002-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04002-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T22:07:04Z","timestamp":1739484424000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04002-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4002"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04002-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol was established, according to the ethical guidelines of the Helsinki Declaration and ethics approval was obtained from the Jinling Hospital, Nanjing University School of Medicine (2021NZKY-032-01). Written informed consent was waived due to the retrospective noninterventional design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of Ethics"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}